Stocks · Health care · Pharmaceutical Preparations

Royalty Pharma plc

RPRX Clue Score45
United States Fiscal year ends December CIK 0001802768
56.93
+1.28%
Close, 9 Oct 2026 · USD

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close
56.93 on 9 Oct 2026
64 50 35 Oct 2025 Apr 2026 Oct 2026 13 Oct 2025 $35.44 14 Oct 2025 $36.00 15 Oct 2025 $36.18 16 Oct 2025 $36.34 17 Oct 2025 $37.01 20 Oct 2025 $36.63 21 Oct 2025 $37.48 22 Oct 2025 $36.84 23 Oct 2025 $36.85 24 Oct 2025 $37.26 27 Oct 2025 $37.26 28 Oct 2025 $36.41 29 Oct 2025 $36.67 30 Oct 2025 $36.94 31 Oct 2025 $37.54 3 Nov 2025 $37.30 4 Nov 2025 $37.84 5 Nov 2025 $40.42 6 Nov 2025 $40.78 7 Nov 2025 $38.56 10 Nov 2025 $38.54 11 Nov 2025 $38.96 12 Nov 2025 $39.59 13 Nov 2025 $39.73 14 Nov 2025 $39.16 17 Nov 2025 $39.16 18 Nov 2025 $39.46 19 Nov 2025 $38.65 20 Nov 2025 $38.39 21 Nov 2025 $38.92 24 Nov 2025 $39.75 25 Nov 2025 $39.54 26 Nov 2025 $39.84 28 Nov 2025 $40.02 1 Dec 2025 $39.90 2 Dec 2025 $39.53 3 Dec 2025 $39.60 4 Dec 2025 $39.15 5 Dec 2025 $39.73 8 Dec 2025 $38.67 9 Dec 2025 $38.09 10 Dec 2025 $38.26 11 Dec 2025 $38.81 12 Dec 2025 $38.39 15 Dec 2025 $38.53 16 Dec 2025 $38.38 17 Dec 2025 $38.31 18 Dec 2025 $38.43 19 Dec 2025 $38.60 22 Dec 2025 $38.86 23 Dec 2025 $39.39 24 Dec 2025 $39.25 26 Dec 2025 $39.22 29 Dec 2025 $39.08 30 Dec 2025 $38.99 31 Dec 2025 $38.64 2 Jan 2026 $38.86 5 Jan 2026 $39.65 6 Jan 2026 $40.65 7 Jan 2026 $41.39 8 Jan 2026 $40.26 9 Jan 2026 $40.17 12 Jan 2026 $40.26 13 Jan 2026 $40.36 14 Jan 2026 $40.21 15 Jan 2026 $39.72 16 Jan 2026 $39.55 20 Jan 2026 $39.09 21 Jan 2026 $39.72 22 Jan 2026 $40.11 23 Jan 2026 $40.40 26 Jan 2026 $40.47 27 Jan 2026 $40.74 28 Jan 2026 $40.41 29 Jan 2026 $40.86 30 Jan 2026 $41.68 2 Feb 2026 $42.36 3 Feb 2026 $42.97 4 Feb 2026 $43.68 5 Feb 2026 $44.10 6 Feb 2026 $44.65 9 Feb 2026 $44.05 10 Feb 2026 $44.21 11 Feb 2026 $44.25 12 Feb 2026 $44.80 13 Feb 2026 $45.19 17 Feb 2026 $45.41 18 Feb 2026 $45.34 19 Feb 2026 $45.11 20 Feb 2026 $45.12 23 Feb 2026 $45.47 24 Feb 2026 $45.40 25 Feb 2026 $45.15 26 Feb 2026 $45.36 27 Feb 2026 $46.21 2 Mar 2026 $47.47 3 Mar 2026 $47.48 4 Mar 2026 $47.43 5 Mar 2026 $45.68 6 Mar 2026 $45.41 9 Mar 2026 $45.84 10 Mar 2026 $45.97 11 Mar 2026 $46.69 12 Mar 2026 $45.87 13 Mar 2026 $45.65 16 Mar 2026 $46.10 17 Mar 2026 $46.11 18 Mar 2026 $45.79 19 Mar 2026 $45.53 20 Mar 2026 $45.36 23 Mar 2026 $45.61 24 Mar 2026 $45.57 25 Mar 2026 $47.03 26 Mar 2026 $46.94 27 Mar 2026 $46.35 30 Mar 2026 $46.37 31 Mar 2026 $47.97 1 Apr 2026 $48.49 2 Apr 2026 $48.57 6 Apr 2026 $47.32 7 Apr 2026 $46.87 8 Apr 2026 $47.90 9 Apr 2026 $48.30 10 Apr 2026 $47.90 13 Apr 2026 $48.43 14 Apr 2026 $48.82 15 Apr 2026 $48.70 16 Apr 2026 $48.48 17 Apr 2026 $50.00 20 Apr 2026 $49.30 21 Apr 2026 $49.48 22 Apr 2026 $49.72 23 Apr 2026 $49.64 24 Apr 2026 $49.38 27 Apr 2026 $49.65 28 Apr 2026 $49.54 29 Apr 2026 $49.49 30 Apr 2026 $50.09 1 May 2026 $49.47 4 May 2026 $50.20 5 May 2026 $50.44 6 May 2026 $50.72 7 May 2026 $50.20 8 May 2026 $50.79 11 May 2026 $51.65 12 May 2026 $51.70 13 May 2026 $53.25 14 May 2026 $53.40 15 May 2026 $52.85 18 May 2026 $52.07 19 May 2026 $52.41 20 May 2026 $53.06 21 May 2026 $53.55 22 May 2026 $54.50 26 May 2026 $53.86 27 May 2026 $53.97 28 May 2026 $54.48 29 May 2026 $55.76 1 Jun 2026 $55.18 2 Jun 2026 $54.01 3 Jun 2026 $54.97 4 Jun 2026 $55.02 5 Jun 2026 $55.87 8 Jun 2026 $54.86 9 Jun 2026 $55.63 10 Jun 2026 $54.52 11 Jun 2026 $55.29 12 Jun 2026 $54.87 15 Jun 2026 $54.27 16 Jun 2026 $54.21 17 Jun 2026 $53.70 18 Jun 2026 $52.96 22 Jun 2026 $53.57 23 Jun 2026 $55.35 24 Jun 2026 $54.28 25 Jun 2026 $54.69 26 Jun 2026 $56.23 29 Jun 2026 $57.09 30 Jun 2026 $56.07 1 Jul 2026 $55.78 2 Jul 2026 $57.77 6 Jul 2026 $56.92 7 Jul 2026 $57.80 8 Jul 2026 $58.37 9 Jul 2026 $57.96 10 Jul 2026 $56.43 13 Jul 2026 $56.45 14 Jul 2026 $55.67 15 Jul 2026 $56.31 16 Jul 2026 $58.53 17 Jul 2026 $58.18 20 Jul 2026 $57.30 21 Jul 2026 $58.42 22 Jul 2026 $58.72 23 Jul 2026 $59.02 24 Jul 2026 $58.83 27 Jul 2026 $58.73 28 Jul 2026 $59.97 29 Jul 2026 $59.18 30 Jul 2026 $59.02 31 Jul 2026 $58.43 3 Aug 2026 $57.17 4 Aug 2026 $57.48 5 Aug 2026 $57.75 6 Aug 2026 $57.26 7 Aug 2026 $56.77 10 Aug 2026 $57.97 11 Aug 2026 $57.79 12 Aug 2026 $59.22 13 Aug 2026 $58.56 14 Aug 2026 $58.60 17 Aug 2026 $59.45 18 Aug 2026 $59.69 19 Aug 2026 $61.73 20 Aug 2026 $60.58 21 Aug 2026 $61.31 24 Aug 2026 $61.33 25 Aug 2026 $62.07 26 Aug 2026 $61.80 27 Aug 2026 $61.92 28 Aug 2026 $60.85 31 Aug 2026 $61.41 1 Sep 2026 $62.32 2 Sep 2026 $63.11 3 Sep 2026 $63.88 4 Sep 2026 $63.96 8 Sep 2026 $60.59 9 Sep 2026 $60.59 10 Sep 2026 $58.75 11 Sep 2026 $58.61 14 Sep 2026 $59.05 15 Sep 2026 $58.47 16 Sep 2026 $58.47 17 Sep 2026 $58.93 18 Sep 2026 $58.41 21 Sep 2026 $58.44 22 Sep 2026 $58.52 23 Sep 2026 $57.65 24 Sep 2026 $58.29 25 Sep 2026 $58.21 28 Sep 2026 $58.37 29 Sep 2026 $58.22 30 Sep 2026 $58.36 1 Oct 2026 $57.63 2 Oct 2026 $57.16 5 Oct 2026 $56.66 6 Oct 2026 $56.44 7 Oct 2026 $56.76 8 Oct 2026 $56.21 9 Oct 2026 $56.93 Coyne Terrance P. EVP & CFO Sold on a plan $2.74M 17 Nov 2025 · at $39.30 · 56.0% of stake Lloyd George W. EVP, Investments & CLO Sold on a plan $115.03K 19 Nov 2025 · at $38.34 · 100% of stake Lloyd George W. EVP, Investments & CLO Sold on a plan $5.08M 19 Nov 2025 · at $38.34 · 100% of stake Coyne Terrance P. EVP & CFO Sold on a plan $2.68M 24 Nov 2025 · at $38.55 · 57.7% of stake Urist Marshall EVP, Research & Investments Sold on a plan $727.86K 1 Dec 2025 · at $39.90 · 41.6% of stake Urist Marshall EVP, Research & Investments Sold on a plan $931.63K 1 Dec 2025 · at $39.93 · 11.3% of stake Coyne Terrance P. EVP & CFO Sold on a plan $2.77M 1 Dec 2025 · at $39.87 · 59.6% of stake Lloyd George W. EVP, Investments & CLO Sold on a plan $4.38M 3 Dec 2025 · at $39.77 · 50.0% of stake Urist Marshall EVP, Research & Investments Sold on a plan $714.22K 5 Dec 2025 · at $39.15 · 71.1% of stake Urist Marshall EVP, Research & Investments Sold on a plan $913.59K 5 Dec 2025 · at $39.15 · 12.7% of stake Coyne Terrance P. EVP & CFO Sold on a plan $2.67M 15 Dec 2025 · at $38.36 · 61.5% of stake Urist Marshall EVP, Research & Investments Sold on a plan $766.42K 16 Dec 2025 · at $38.32 · 12.5% of stake Lloyd George W. EVP, Investments & CLO Sold on a plan $3.06M 17 Dec 2025 · at $38.57 · 72.1% of stake Lloyd George W. EVP, Investments & CLO Sold on a plan $1.18M 18 Dec 2025 · at $38.50 · 100% of stake Urist Marshall EVP, Research & Investments Sold on a plan $767.58K 19 Dec 2025 · at $38.38 · 14.3% of stake Urist Marshall EVP, Research & Investments Sold on a plan $786.38K 26 Dec 2025 · at $39.32 · 16.7% of stake Urist Marshall EVP, Research & Investments Sold on a plan $769.65K 2 Jan 2026 · at $38.48 · 20.0% of stake Coyne Terrance P. EVP & CFO Sold on a plan $2.67M 2 Jan 2026 · at $38.42 · 63.6% of stake Urist Marshall EVP, Research & Investments Sold on a plan $815.63K 9 Jan 2026 · at $40.78 · 25.0% of stake Urist Marshall EVP, Research & Investments Sold on a plan $790.35K 16 Jan 2026 · at $39.52 · 33.3% of stake Coyne Terrance P. EVP & CFO Sold on a plan $2.74M 20 Jan 2026 · at $39.35 · 65.9% of stake Urist Marshall EVP, Research & Investments Sold on a plan $805.11K 23 Jan 2026 · at $40.26 · 50.0% of stake Urist Marshall EVP, Research & Investments Sold on a plan $821.81K 30 Jan 2026 · at $41.09 · 100% of stake Coyne Terrance P. EVP & CFO Sold on a plan $4.56M 2 Feb 2026 · at $42.08 · 78.2% of stake Coyne Terrance P. EVP & CFO Sold on a plan $4.92M 3 Feb 2026 · at $42.84 · 82.7% of stake Coyne Terrance P. EVP & CFO Sold on a plan $872.91K 4 Feb 2026 · at $43.29 · 46.8% of stake Coyne Terrance P. EVP & CFO Sold on a plan $1.58M 23 Feb 2026 · at $45.32 · 42.2% of stake Coyne Terrance P. EVP & CFO Sold on a plan $1.63M 2 Mar 2026 · at $46.78 · 43.2% of stake Coyne Terrance P. EVP & CFO Sold on a plan $1.58M 23 Mar 2026 · at $45.53 · 44.2% of stake Coyne Terrance P. EVP & CFO Sold on a plan $1.68M 1 Apr 2026 · at $48.33 · 51.4% of stake Coyne Terrance P. EVP & CFO Sold on a plan $1.73M 28 Apr 2026 · at $49.78 · 100% of stake Norden Gregory Director Sold on a plan $161.39K 14 May 2026 · at $53.00 · 1.6% of stake Urist Marshall EVP, Research & Investments Sold on a plan $726.14K 14 May 2026 · at $53.06 · 30.0% of stake Urist Marshall EVP, Research & Investments Sold on a plan $721.84K 20 May 2026 · at $52.75 · 42.9% of stake Coyne Terrance P. EVP & CFO Sold on a plan $3.48M 26 May 2026 · at $53.98 · 100% of stake Hite Christopher EVP & Chairman, Partnering Sold on a plan $8.16M 23 Jun 2026 · at $54.40 · 21.1% of stake Urist Marshall EVP, Research & Investments Sold on a plan $502.07K 24 Jun 2026 · at $55.18 · 50.0% of stake Hite Christopher EVP & Chairman, Partnering Sold on a plan $1.69M 30 Jun 2026 · at $56.46 · 42.9% of stake Hite Christopher EVP & Chairman, Partnering Sold on a plan $5.65M 30 Jun 2026 · at $56.52 · 17.9% of stake Urist Marshall EVP, Research & Investments Sold on a plan $508.45K 1 Jul 2026 · at $55.88 · 100% of stake Coyne Terrance P. EVP & CFO Sold on a plan $645.55K 13 Aug 2026 · at $58.68 · 100% of stake Hite Christopher EVP & Chairman, Partnering Sold on a plan $6.00M 18 Aug 2026 · at $59.97 · 21.3% of stake Hite Christopher EVP & Chairman, Partnering Sold on a plan $5.85M 22 Sep 2026 · at $58.53 · 27.0% of stake Urist Marshall EVP, Research & Investments Sold on a plan $238.81K 28 Sep 2026 · at $57.88 · 50.0% of stake Urist Marshall EVP, Research & Investments Sold on a plan $235.59K 5 Oct 2026 · at $57.10 · 100% of stake
0 buys0 sales at will45 planned sales

Key numbers

Fiscal year 2025, ended 31 Dec 2025, as filed
Revenue
$2.38B
Net income
$770.95M
Free cash flow
$2.49B
Operating margin
65.6%
Net margin
32.4%
Return on equity
7.9%
Return on capital
8.4%
Debt to equity
0.92
Revenue growth, 1 yr
5.1%
Revenue growth, 5 yr
2.3% a year
EPS growth, 1 yr
-6.8%

Revenue and net income

Fiscal years, as filed with the SEC · point at a year for the detail
2.1B 975M FY20 Fiscal year 2020 Revenue $2.12B Net income $975.04M Margin 45.9% 2.3B 620M FY21 Fiscal year 2021 Revenue $2.29B Net income $619.73M Margin 27.1% · growth +7.9% 2.2B 43M FY22 Fiscal year 2022 Revenue $2.24B Net income $42.83M Margin 1.9% · growth -2.3% 2.4B 1.1B FY23 Fiscal year 2023 Revenue $2.35B Net income $1.13B Margin 48.2% · growth +5.2% 2.3B 859M FY24 Fiscal year 2024 Revenue $2.26B Net income $858.98M Margin 37.9% · growth -3.9% 2.4B 771M FY25 Fiscal year 2025 Revenue $2.38B Net income $770.95M Margin 32.4% · growth +5.1%
RevenueNet incomeLoss

Latest insider transactions

From Form 4, most recent first
All of them →
DateInsiderTypeValueOf own stake
5 Oct 2026 Urist Marshall
EVP, Research & Investments
Sold on a plan $235.59K 100%
28 Sep 2026 Urist Marshall
EVP, Research & Investments
Sold on a plan $238.81K 50.0%
22 Sep 2026 Hite Christopher
EVP & Chairman, Partnering
Sold on a plan $5.85M 27.0%
18 Aug 2026 Hite Christopher
EVP & Chairman, Partnering
Sold on a plan $6.00M 21.3%
13 Aug 2026 Coyne Terrance P.
EVP & CFO
Sold on a plan $645.55K 100%
1 Jul 2026 Urist Marshall
EVP, Research & Investments
Sold on a plan $508.45K 100%